EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects

Urmila Kafle iD, Hoang Quan Truong, Cao Thuy Giang Nguyen, Fanfei Meng iD

Molecular Pharmaceutics · 02.12.2024 · 21 (12) · 5944-5959

DOI: 10.1021/acs.molpharmaceut.4c00826 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 12.11.2024. Verfasst von Urmila Kafle und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell, 3 Solomont Way, Lowell, Massachusetts 01854, United States. Hauptthemen laut MEDLINE: RNA, Messenger, SARS-CoV-2. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: University of Massachusetts Lowell.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The success of mRNA-LNP-based COVID-19 vaccines opens a new era for mRNA-LNP-based therapy. This breakthrough is expected to catalyze the development of more mRNA-LNP-based medicines, not only for preventive vaccines but also for therapeutic purposes. Despite the promising outlook, there are fundamental challenges impeding the progress and widespread application of mRNA-LNP formulations. One of the significant challenges is their thermal instability, requiring these products to be stored at ultralow temperatures for long-term stability. The specific requirements present significant challenges for the storage, transportation, and distribution of mRNA-LNP formulations. To effectively prepare for future infectious disease outbreaks and broaden the application of mRNA-LNP-based therapies for other illnesses, improving the thermostability of mRNA-LNP formulations is critical. In this review, we discuss the potential factors contributing to the thermal instability of mRNA-LNP formulations and examine the roles of key components such as ionizable lipids, cholesterol, pH, buffers, and stabilizing agents like sugars in maintaining their thermal stability, with the goal of providing insights that can guide the future development of thermally stable mRNA-LNP formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerSARS-CoV-2HumansCOVID-19COVID-19 VaccinesLipidsDrug Delivery SystemsTemperatureDrug StabilityNanoparticles

Stichwörter der Autor:innen

FormulationsFunctional stabilityLipid nanoparticlesPhysicochemical stabilityThermal stabilitymRNA

Substanzen

RNA, MessengerCOVID-19 VaccinesLipids

Autor:innen und Institutionen

  • Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell, 3 Solomont Way, Lowell, Massachusetts 01854, United States.

ORCID-Profile: Urmila Kafle, Fanfei Meng

Förderung

  • University of Massachusetts Lowell

Zitieren

APA

Kafle, U., Truong, H. Q., Nguyen, C. T. G., & Meng, F. (2024). Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects. Molecular Pharmaceutics, 21(12), 5944-5959. https://doi.org/10.1021/acs.molpharmaceut.4c00826

Vancouver

Kafle U, Truong HQ, Nguyen CTG, Meng F. Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects. Molecular Pharmaceutics. 2024;21(12):5944-5959. doi:10.1021/acs.molpharmaceut.4c00826

BibTeX
@article{Kafle2024,
  author = {Kafle, Urmila and Truong, Hoang Quan and Nguyen, Cao Thuy Giang and Meng, Fanfei},
  title = {Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  volume = {21},
  number = {12},
  pages = {5944--5959},
  doi = {10.1021/acs.molpharmaceut.4c00826}
}
Kostenlos starten →